Should I buy Bath & Body Works, Inc. (BBWI) stock or is it too late?

Bath & Body Works, Inc. · Consumer Discretionary · price $18

See the full Bath & Body Works, Inc. (BBWI) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 61% of its targets hit on this sector (220 calls tested). It aims for $17 (-5.6 %), call made on August 28, 2026, maturing on August 28, 2027 (47 d ago).

The 4 reliable analysts $21.50+19 %

The 8 other firms $22.50+25 %

How to read it: the 4 reliable firms are not filtered by optimism — 3 aim above the price, 1 below, hence their $21.50 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Bath & Body Works, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
BMO Capital	17 %	-12.1 %	6	$20 +11%
Baird	12 %	-16.4 %	8	$23 +28%
Telsey Advisory Group	26 %	-18.1 %	39	$22 +22%
Goldman Sachs	0 %	-18.7 %	8	$19 +6%
Morgan Stanley	18 %	-20.6 %	11	$20 +11%
Wells Fargo	12 %	-24.9 %	8	$24 +33%
Citigroup	12 %	-26.5 %	8	$25 +39%
JP Morgan	0 %	-31.1 %	7	$24 +33%

In short — Should you invest in Bath & Body Works, Inc.? Is it too late, still worth it? Analysts are split (23% buy, median target $23, i.e. +25%), and the most reliable on BBWI targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $23, i.e. +25% from the current price ($18).
The most reliable firm on BBWI, Barclays (100% hit rate, 3 scored calls), targets $22 (call made on August 27, 2026, maturing on August 27, 2027) (+22%) in its most recent call, and $28 (call made on October 20, 2025, maturing on October 20, 2026) (+56%) in the one coming due soonest.
Pays a dividend (3.6% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 13 ratings, 9 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on BBWI

Median target $23 (+25%) · 13 ratings · Hold consensus

Strong Buy00%

Buy323%

Hold969%

Sell18%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Bath & Body Works, Inc. now?

We won't decide for you. The facts: 23% of analysts rate it a buy, median target $23 (+25%), and Barclays (most reliable on BBWI, 100%) targets $22. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Bath & Body Works, Inc.?

Not according to analysts: the median target ($23) is still +25% above the current price ($18) (most reliable on BBWI: Barclays, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Bath & Body Works, Inc. still worth investing in?

It depends on the gap between the price ($18) and its estimated value: analysts target $23 on median (+25%), with 23% buys (most reliable on BBWI: Barclays, 100%). Cross-check with their real reliability on BBWI and the cautions above. Information, not advice.

What's the main risk in buying BBWI?

The consensus is not unanimous: of 13 ratings, 9 are neutral and 1 is a sell.

→ Go deeper: the full Bath & Body Works, Inc. profile (consensus, analyst reliability, price target, performance).